semaglutide effect on brain Therapeutic Potential of Semaglutide, a Newer GLP-1 Receptor Agonist, in Abating Obesity, Non-Alcoholic Steatohepatitis and Neurodegenerative diseases: A Narrative Review | Pharmaceutical Research The Unexplored Effects of Weight-Loss

And we concur

Could your lifestyle choices be influencing your progress

S one stosowane u osb z wysokim BMI lub z chorobami wspistniejcymi, gdy dieta i aktywno fizyczna nie przynosz oczekiwanych efektw

Only a small number of categories show increases, and those increases are modest relative to the overall decline. However, this decline in food spending appears to evaporate if a person stops taking their GLP-1 drug or adopts a lower maintenance dose, researchers said

Conclusion This study suggested a bidirectional causal relationship between T2D and SA, with GLP-1-RAs potentially serving as a therapeutic target for SA